Deferasirox: A Review of its Use in the Management of Transfusional Chronic Iron Overload

Author： Yang Lily P.H.   Keam Susan J.   Keating Gillian M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.15, 2007-01, pp. : 2211-2230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deferasirox: a guide to its use in transfusional chronic iron overload

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 2, 2008-02 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload

By Cappellini MD   Taher A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2391-2402

Informa Healthcare

Access to resources Recommend Favorite

Oral deferasirox may be an effective iron chelator in patients with thalassaemia and transfusional iron overload

By  

Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Deferasirox dominates deferoxamine for iron overload

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 665, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Optimal Management Strategies for Chronic Iron Overload

By Barton James C.  

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 685-700

Adis International

Access to resources Recommend Favorite